Tumor BRCA1 & BRCA2 Gene Analysis

Tumor BRCA1 and BRCA2 Gene Analysis is a crucial diagnostic tool in oncology specially in Breast, Ovarian, Prostate and pancreatic Cancers. These genes, responsible for homologous recombination repair of damaged DNA, play a pivotal role in maintaining genomic integrity. Mutations in BRCA1 and BRCA2 can impair DNA repair mechanisms, making tumors susceptible to PARP inhibitor therapy. This analysis provides essential insights into a patient's DNA repair deficiency, aiding in determining their eligibility for treatment with specific PARP inhibitors. It aligns with approved therapeutic guidelines, offering personalized treatment options for cancer patients and potentially improving their outcomes.

Disclaimer: In no event shall the liability of TATA 1MG exceed the amount of actual cost of test charges incurred by the customer as stated on the invoice issued by Tata 1mg.